Breaking News

Par Pharma Appoints Commercial Officer

By Kristin Brooks | February 21, 2014

JHP’s Pera brings more than 30 years of industry experience

Antonio R. Pera has been named chief commercial officer at Par Pharmaceutical Companies. Mr. Pera will lead Par's newly-integrated sales and marketing organization following its acquisition of JHP Pharmaceuticals, and will manage relationships with its major trade partners.
 
Mr. Pera was previously with JHP, where he served as senior vice president, commercial operations. He has more than 30 years of experience in the pharma industry, including manufacturing and wholesale for generic and branded products. Prior to JHP, Mr. Pera was senior vice president, supply chain management at AmerisourceBergen Corp., where he served as a corporate officer and led the procurement function.
 
"Tony has enjoyed a distinguished career in the pharmaceutical industry and we are very pleased to have him join the Par team," said Paul V. Campanelli, chief executive officer of Par Pharmaceutical Companies. "He has a demonstrated expertise in the marketing, sales and distribution of generic drugs. We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks